NOTCH1 and acute lymphoblastic leukemia: Pre-clinical studies show encouraging results with GSIs treatment of T-ALL cell lines resulting in the rapid clearance of activated Notch1 and the transcriptional down-regulation of its target genes, with consequent decrease in tumor cell growth and proliferation due to G1 cell cycle arrest [7, 59].